These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21898494)

  • 1. Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers?
    Mato JM; Lu SC
    Hepatology; 2011 Oct; 54(4):1115-7. PubMed ID: 21898494
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nonalcoholic steatohepatitis: epidemiology, diagnosis and treatment].
    Tilg H
    Dtsch Med Wochenschr; 2001 Apr; 126(16):467-71. PubMed ID: 11360453
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease: a challenge for pediatricians.
    Widhalm K; Ghods E
    Int J Obes (Lond); 2010 Oct; 34(10):1451-67. PubMed ID: 20838401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
    Munteanu M; Ratziu V; Morra R; Messous D; Imbert-Bismut F; Poynard T
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):187-91. PubMed ID: 18568141
    [No Abstract]   [Full Text] [Related]  

  • 5. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins.
    Bookman ID; Pham J; Guindi M; Heathcote EJ
    Liver Int; 2006 Jun; 26(5):566-71. PubMed ID: 16762001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.
    Schwimmer JB
    Semin Liver Dis; 2007 Aug; 27(3):312-8. PubMed ID: 17682977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric nonalcoholic fatty liver disease: a comprehensive review.
    Lindbäck SM; Gabbert C; Johnson BL; Smorodinsky E; Sirlin CB; Garcia N; Pardee PE; Kistler KD; Schwimmer JB
    Adv Pediatr; 2010; 57(1):85-140. PubMed ID: 21056736
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, fatty liver and liver cancer.
    Qian Y; Fan JG
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):173-7. PubMed ID: 15908310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non alcoholic steatohepatitis.
    Zantout H; Barada K
    J Med Liban; 2001; 49(2):90-3. PubMed ID: 11910973
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nonalcoholic steatohepatitis--current treatment options].
    Gutkowski K; Gutkowska D; Partyka M
    Przegl Lek; 2006; 63(2):91-4. PubMed ID: 16967716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease in children.
    Alisi A; Locatelli M; Nobili V
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):397-402. PubMed ID: 20531177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nonalcoholic steatohepatitis].
    Jin SY
    Korean J Hepatol; 2006 Sep; 12(3):455-9. PubMed ID: 16998299
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonalcoholic steatohepatitis: risk factors and diagnosis.
    Adams LA; Feldstein AE
    Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):623-35. PubMed ID: 20932147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical update on non-alcoholic fatty liver disease and steatohepatitis.
    Bugianesi E; Bellentani S; Bedogni G; Tiribelli C;
    Ann Hepatol; 2008; 7(2):157-60. PubMed ID: 18626435
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical features of NASH].
    Shimada M; Takase S
    Nihon Rinsho; 2006 Jun; 64(6):1114-8. PubMed ID: 16768118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of various diagnostic parameters in chronic liver diseases].
    Heinicke HJ
    Z Gesamte Inn Med; 1973 Feb; 28(4):93-101. PubMed ID: 4540734
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients.
    Manousou P; Kalambokis G; Grillo F; Watkins J; Xirouchakis E; Pleguezuelo M; Leandro G; Arvaniti V; Germani G; Patch D; Calvaruso V; Mikhailidis DP; Dhillon AP; Burroughs AK
    Liver Int; 2011 May; 31(5):730-9. PubMed ID: 21457446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric nonalcoholic fatty liver disease in 2009.
    Alisi A; Manco M; Vania A; Nobili V
    J Pediatr; 2009 Oct; 155(4):469-74. PubMed ID: 19772998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.